Lv719
3800 积分 2021-09-06 加入
Secondary stroke prevention in people with atrial fibrillation: treatments and trials
4小时前
已完结
Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study
4小时前
已完结
Risk of Intracranial Hemorrhage Caused by Direct Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation (from a Network Meta-Analysis of Randomized Controlled Trials)
5小时前
已完结
Delaying clinical events among patients with non-valvular atrial fibrillation treated with oral anticoagulants: Insights from the ARISTOPHANES study
1天前
已完结
Rivaroxaban and Post-Stroke Neurological Outcomes in Patients With Acute Coronary Syndrome
9天前
已完结
Comparative Effectiveness of Sacubitril/Valsartan Versus Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Patients with De Novo Heart Failure with Mildly Reduced and Preserved Ejection Fraction
20天前
已完结
Higher Risk of Kidney Failure Associated with Angiotensin Receptor Blockers Versus ACE Inhibitors in Patients with Heart Failure
21天前
已关闭
Effects of Sacubitril/Valsartan According to Background Beta-Blocker Therapy in Patients with Heart Failure and Reduced Ejection Fraction: Insights from PARADIGM-HF
24天前
已完结
Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction
24天前
已完结
Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure
24天前
已完结
皖公网安备34019202002308
